Sign Up Today and Learn More About Kronos Bio Stock
Invest in or calculate the value of your shares in Kronos Bio or other pre-IPO companies through EquityZen's platform.
Kronos Bio Stock
Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets.
About Kronos Bio Stock
Founded
2017
Headquarters
San Mateo, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling. . In 2017, Angela Koehler, Christopher Wilfong​, and Joshua A. Kazam established Kronos Bio in San Mateo California.
Kronos Bio Management
Leadership team at Kronos Bio
Vice President, Program Management
Christopher Lee
Vice President, Pharmacology
Douglas C. Saffran
Join now and verify your accreditation status to gain access to:
- Kronos Bio current valuation
- Kronos Bio stock price
- Available deals in Kronos Bio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Kronos Bio stock?
Accredited investors can buy pre-IPO stock in companies like Kronos Bio through EquityZen funds. These investments are made available by existing Kronos Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kronos Bio stock?
Shareholders can sell their Kronos Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
